Latest filing published 20 Nov 2012 for Vertex Pharmaceuticals INC / MA, €354k.
Insider track record
No signal scores available.
Matthew Emmens: trading record in brief
This profile gathers the share dealings of Matthew Emmens in Vertex Pharmaceuticals INC / MA. We count 9 filings; the first trade dates from 5 February 2009 and the latest from 16 November 2012.
The open-market record consists of 5 sales worth €2.3M, with no purchase. Besides market trades, the filings include 4 share grants. 2012 to date brings no purchases and 4 sales.
The newest entry dates from 20 November 2012: an open-market sale of €354k, in Vertex Pharmaceuticals INC / MA. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Matthew Emmens
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,850 shares@ US$41.76Common StockSEC:0001209191-12-054064:0
- 2,500 shares@ US$36.39Common StockSEC:0001209191-12-008147:0
- 12,900 shares@ US$37.11Common StockSEC:0001209191-12-008147:1
- 40,600 shares@ US$38.08Common StockSEC:0001209191-12-008147:2
- 47,201 shares@ US$0.01Common StockSEC:0001209191-12-007770:0
- 9,735 shares@ US$55.51Common StockSEC:0001209191-11-031209:0
- 47,201 shares@ US$0.01Common StockSEC:0000875320-11-000008:0
- 47,201 shares@ US$0.01Common StockSEC:0000875320-10-000009:0
- 134,129 shares@ US$0.01Common StockSEC:0000875320-09-000009:0
9 of 9 declarations
